Quantitation of matrix metalloproteinases in cultured rat astrocytes using the polymerase chain reaction with a multi‐competitor cDNA standard

No abstract is available for this paper.

• Publication year

  1996

• Venue

  Glia

• Publication date

  1996-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/(SICI)1098-1136(199612)18:4<332::AID-GLIA7>3.0.CO;2-ZPMID 8972801
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Expression of the stromelysin-3 gene in fibroblastic cells of invasive carcinomas of the breast and other human tissues: a review

  2005cited by this paper
• Matrix metalloproteinases degrade myelin basic protein.

  1995cited by this paper
• Cytokines Regulate Gelatinase A and B (Matrix Metalloproteinase 2 and 9) Activity in Cultured Rat Astrocytes

  1995cited by this paper
• Membrane-type matrix metalloproteinase (MT-MMP) gene is expressed in stromal cells of human colon, breast, and head and neck carcinomas.

  1995cited by this paper
• A metalloprotease inhibitor blocks shedding of the 80-kD TNF receptor and TNF processing in T lymphocytes

  1995cited by this paper
• The C-terminal Region of Membrane Type Matrix Metalloproteinase Is a Functional Transmembrane Domain Required for Pro-gelatinase A Activation (*)

  1995cited by this paper
• Processing of tumour necrosis factor-alpha precursor by metalloproteinases.

  1994cited by this paper
• Distinct populations of basal keratinocytes express stromelysin-1 and stromelysin-2 in chronic wounds.

  1994cited by this paper
• Protection against a lethal dose of endotoxin by an inhibitor of tumour necrosis factor processing

  1994cited by this paper
• Hydrolytic inactivation of a breast carcinoma cell-derived serpin by human stromelysin-3.

  1994cited by this paper
• Reversal of experimental autoimmune encephalomyelitis with a hydroxamate inhibitor of matrix metalloproteases.

  1994cited by this paper
• Limitations and modifications of quantitative polymerase chain reaction. Application to measurement of multiple mRNAs present in small amounts of sample RNA.

  1993cited by this paper
• Gelatinase B is present in the cerebrospinal fluid during experimental autoimmune encephalomyelitis and cleaves myelin basic protein

  1993cited by this paper
• Involvement of a metalloprotease in low-affinity nerve growth factor receptor truncation: inhibition of truncation in vitro and in vivo

  1993cited by this paper
• Leukocyte gelatinase B cleavage releases encephalitogens from human myelin basic protein.

  1993cited by this paper
• Molecular profile of reactive astrocytes—Implications for their role in neurologic disease

  1993cited by this paper
• Matrix metalloproteinases: a review.

  1993cited by this paper
• TIMP-2 reduces proteolytic opening of blood-brain barrier by type IV collagenase.

  1992cited by this paper
• A novel coumarin‐labelled peptide for sensitive continuous assays of the matrix metalloproteinases

  1992cited by this paper
• Gelatinase in the cerebrospinal fluid of patients with multiple sclerosis and other inflammatory neurological disorders.

  1992cited by this paper
• Standardization of mRNA titration using a polymerase chain reaction method involving co-amplification with a multispecific internal control.

  1992cited by this paper
• Use of quantitative polymerase chain reaction to quantitate cytokine messenger RNA molecules.

  1992cited by this paper
• Eicosanoid forming enzyme mRNA in human tissues. Analysis by quantitative polymerase chain reaction.

  1991cited by this paper
• Human immunodeficiency virus-infected individuals contain provirus in small numbers of peripheral mononuclear cells and at low copy numbers

  1990cited by this paper
• Analysis of cytokine mRNA and DNA: detection and quantitation by competitive polymerase chain reaction.

  1990cited by this paper
• Expression of metalloproteinases and metalloproteinase inhibitors by fetal astrocytes and glioma cells.

  1990cited by this paper
• Absolute mRNA quantification using the polymerase chain reaction (PCR). A novel approach by a PCR aided transcript titration assay (PATTY).

  1989cited by this paper
• Quantitation of mRNA by the polymerase chain reaction.

  1989cited by this paper
• Preparation of separate astroglial and oligodendroglial cell cultures from rat cerebral tissue

  1980cited by this paper

• Matrix Metalloproteinases in Parasitic Infections

  2017cites this paper
• Therapeutically targeting astrocytes with stem and progenitor cell transplantation following traumatic spinal cord injury.

  2015cites this paper
• ligament in a rat MCL model Blockade of the sympathetic nervous system degrades

  2015cites this paper
• Increased Expression of p-Akt correlates with Chronic Allograft Nephropathy in a Rat Kidney Model

  2014cites this paper
• Metalloproteinases and metalloproteinase inhibitors in age-related diseases.

  2014cites this paper
• Osteopontin Expression During the Acute Immune Response Mediates Reactive Synaptogenesis and Adaptive Outcome

  2013influential citation
• The Significance of Matrix Metalloproteinases in Parasitic Infections Involving the Central Nervous System

  2013cites this paper
• Small serum protein-1 changes the susceptibility of an apoptosis-inducing metalloproteinase HV1 to a metalloproteinase inhibitor in habu snake (Trimeresurus flavoviridis).

  2013cites this paper
• MT5-MMP, ADAM-10, and N-Cadherin Act in Concert To Facilitate Synapse Reorganization after Traumatic Brain Injury

  2012cites this paper
• Neural tissue engineering and biohybridized microsystems for neurobiological investigation in vitro (Part 1).

  2011cites this paper
• Astrocytic beta(2)-adrenergic receptors: from physiology to pathology.

  2010cites this paper
• Membrane-bound Matrix Metalloproteinases Influence Reactive Synaptogenesis Following Traumatic Brain Injury

  2010cites this paper
• Chapter 5 – Glycotranscriptomics

  2010cites this paper
• Optimization of 3-D neural culture and extracellular electrophysiology for studying injury-induced morphological and functional changes

  2010cites this paper
• Polyclonal immunoglobulins (IVIg) induce expression of MMP-9 in microglia.

  2009cites this paper
• The astrocyte odyssey.

  2008cites this paper
• The Role of Oxidative Stress, Metabolic Compromise, and Inflammation in Neuronal Injury Produced by Amphetamine-Related Drugs of Abuse

  2008cites this paper
• MMPs and other matrix-degrading metalloproteinases in neurological disease

  2007cites this paper
• Effects of hyperbaric oxygen on gene expressions of procollagen, matrix metalloproteinase and tissue inhibitor of metalloproteinase in injured medial collateral ligament and anterior cruciate ligament

  2007cites this paper
• MatrixMetalloproteinasesExpressedbyAstrocytesMediate ExtracellularAmyloid-PeptideCatabolism

  2006cites this paper
• Hepatocyte production of modulators of extracellular liver matrix in normal and cirrhotic rat liver.

  2006cites this paper
• Roles of an extracellular matrix (ECM) receptor and ECM processing enzymes in demyelinating canine distemper encephalitis.

  2006cites this paper
• Matrix Metalloproteinases Expressed by Astrocytes Mediate Extracellular Amyloid-β Peptide Catabolism

  2006cites this paper
• IL‐1‐regulated responses in astrocytes: Relevance to injury and recovery

  2005cites this paper
• Characterisation of inflammation in the central nervous system induced by lipoteichoic acid from Staphylococcus aureus : role of glia in the mechanisms of neuronal cell death

  2005cites this paper
• Matrix Metalloproteinases and Proteolytic Opening of the Blood–Brain Barrier in Neuroinflammation

  2005cites this paper
• Characterization of Mca-Lys-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2, a fluorogenic substrate with increased specificity constants for collagenases and tumor necrosis factor converting enzyme.

  2004cites this paper
• Blockade of the sympathetic nervous system degrades ligament in a rat MCL model.

  2004cites this paper
• Matrix metalloproteinases in neuroinflammation and cerebral ischemia.

  2004cites this paper
• Induction of matrix metalloproteinase-9 in murine eosinophilic meningitis caused by Angiostrongylus cantonensis

  2004cites this paper
• Association of matrix metalloproteinase-9 in eosinophilic meningitis of BALB/c mice caused by Angiostrongylus cantonensis

  2004cites this paper
• Matrix metalloproteinases and infectious diseases

  2004cites this paper
• Decreased collagen-degrading activity could be a marker of prolonged mesangial matrix expansion

  2004cites this paper
• Phase-dependent expression of matrix metalloproteinases and their inhibitors in demyelinating canine distemper encephalitis

  2003cites this paper
• The Effect of Mitomycin on Extracellular Matrix Proteins in a Rat Wound Model

  2003cites this paper
• Unbalanced collagenases/TIMP-1 expression and epithelial apoptosis in experimental lung fibrosis.

  2003cites this paper
• Differential Effect of p47phox and gp91phox Deficiency on the Course of Pneumococcal Meningitis

  2003cites this paper
• TACE mRNA expression in peripheral mononuclear cells precedes new lesions on MRI in multiple sclerosis

  2002cites this paper
• Comparison of matrix metalloproteinase expression during Wallerian degeneration in the central and peripheral nervous systems.

  2002cites this paper
• TWEAK is expressed by glial cells, induces astrocyte proliferation and increases EAE severity.

  2002cites this paper
• Effect of preoperative radiotherapy on matrilysin gene expression in rectal cancer.

  2002cites this paper
• Stromelysin-1 (Matrix Metalloproteinase-3) and Tissue Inhibitor of Metalloproteinase-3 Are Overexpressed in the Wall of Abdominal Aortic Aneurysms

  2002cites this paper
• Matrix metalloproteinases in neuroinflammation

  2002cites this paper
• Matri xMetalloproteinase sin Neuroinflammation

  2002cites this paper
• Matrix metalloproteases and their inhibitors are produced by overlapping populations of activated astrocytes.

  2002cites this paper
• Matrix Metalloproteinase-9 Undergoes Expression and Activation during Dendritic Remodeling in Adult Hippocampus

  2002influential citation
• Quantitative reverse transcription-polymerase chain reaction (RT-PCR): a comparison of primer-dropping, competitive, and real-time RT-PCRs.

  2002cites this paper
• Stromelysin-1 and gelatinase A are upregulated before TNF-alpha in LPS-stimulated neuroinflammation.

  2002cites this paper
• Evidence that MMP-2 and TIMP-2 are at play in the FSH-induced changes in Sertoli cells.

  2002cites this paper
• Up‐regulation of MMP‐8 and MMP‐9 activity in the BALB/c mouse spinal cord correlates with the severity of experimental autoimmune encephalomyelitis

  2002cites this paper
• Renal Matrix Metalloproteinase Activity Is Unaffected by Experimental Ischemia-Reperfusion Injury and Matrix Metalloproteinase Inhibition Does Not Alter Outcome of Renal Function

  2001cites this paper
• Spectrum of matrix metalloproteinase expression in primary and metastatic colon cancer: relationship to the tissuenhibitors of metalloproteinases and membrane type-1-matrix metalloproteinase

  2001cites this paper
• Association of increased phosphatidylinositol 3-kinase signaling with increased invasiveness and gelatinase activity in malignant gliomas.

  2001cites this paper
• Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human optic nerve head astrocytes

  2001cites this paper
• MT1-MMP in rat testicular development and the control of Sertoli cell proMMP-2 activation.

  2001cites this paper
• Monitoring MMP and TIMP mRNA expression by RT-PCR.

  2001cites this paper
• Absence of Detectable IL‐1β Production in Murine Prion Disease: A Model of Chronic Neurodegeneration

  2001cites this paper
• Senescent expression of genes coding collagens, collagen-degrading metalloproteinases, and tissue inhibitors of metalloproteinases in rat vocal folds: comparison with skin and lungs.

  2001cites this paper
• Microvessel integrin expression during focal cerebral ischemia

  2001cites this paper
• Human immunodeficiency virus type-1 Nef protein induces blood-brain barrier disruption in the rat: role of matrix metalloproteinase-9.

  2000cites this paper
• Dexamethasone regulation of matrix metalloproteinase expression in CNS vascular endothelium.

  2000cites this paper
• A central role for astrocytes in the inflammatory response to beta-amyloid; chemokines, cytokines and reactive oxygen species are produced.

  1999cites this paper
• Vacuolation in murine prion disease: an informative artifact.

  1999cites this paper
• Matrix metalloproteinases in neuro-inflammatory disease

  1999cites this paper
• Extracellular matrix degradation by metalloproteinases and central nervous system diseases

  1999cites this paper
• Differential expression of matrix metalloproteinases in bacterial meningitis.

  1999cites this paper
• Expression of extracellular matrix degrading enzymes during migration of xenografted brain cells

  1999cites this paper
• The matrix metalloproteinase inhibitor BB‐1101 prevents experimental autoimmune uveoretinitis (EAU)

  1999cites this paper
• CXC chemokines generate age-related increases in neutrophil-mediated brain inflammation and blood-brain barrier breakdown.

  1998cites this paper
• Matrix metalloproteinase-9 (gelatinase B) is selectively elevated in CSF during relapses and stable phases of multiple sclerosis.

  1998cites this paper
• Matrix metalloproteinase expression in an experimentally-induced DTH model of multiple sclerosis in the rat CNS.

  1998cites this paper
• Matrix metalloproteinase-9 and -7 are regulated in experimental autoimmune encephalomyelitis.

  1998influential citation
• Matrix metalloproteinases MMP‐9 and MMP‐7 are expressed in experimental autoimmune neuritis and the guillain‐barré syndrome

  1998cites this paper
• Matrix metalloproteinase expression during experimental autoimmune neuritis.

  1998influential citation
• Matrix metalloproteinases, tumor necrosis factor and multiple sclerosis: an overview.

  1997cites this paper
• Matrix metalloproteinases in experimental autoimmune encephalomyelitis.

  1997cites this paper
• Matrix metalloproteinase expression during experimental autoimmune encephalomyelitis and effects of a combined matrix metalloproteinase and tumour necrosis factor-alpha inhibitor.

  1997cites this paper
• NOTES & TIPS

  year unknowncites this paper